论文部分内容阅读
进入二季度,己内酰胺市场迎来一波上涨行情,4月份涨幅达到5.19%,5月份幅度2.47%,6月份市场价格上涨了400~600元(吨价,下同)。此番上涨是由上游纯苯价格上涨以及库存快速消化引发。后市随着天辰耀隆等新装置产能陆续释放,供应面将形成利空。业内人士认为,此番上涨行情难以长久。产能集中释放我国己内酰胺产能自2011年开始迅速释放,从2011年之前的59万吨/年左右扩增至2012年的111.5万吨/年,一年内几乎翻了一番。之后产能增
Into the second quarter, the caprolactam market ushered in a wave of rising prices, in April rose to 5.19%, the May amplitude of 2.47%, the market price in June rose 400 to 600 yuan (t price, the same below). This rise is caused by the upper reaches of pure benzene prices and inventory rapid digestion triggered. With the market outlook, Tianchen Yaolong and other new device capacity gradually released, the supply side will be formed negative. The industry believes that this time up the market is difficult to long-term. Centralized release of capacity Caprolactam production capacity in China has been rapidly released since 2011, expanding from about 590,000 tons / year before 2011 to 1,115,000 tons / year in 2012, almost doubling in one year. After production capacity increase